Literature DB >> 15506918

The ubiquitous phosphoinositides.

P J Parker1.   

Abstract

There are now known to exist seven phosphoinositides all derived through various metabolic routes from the parent lipid phosphatidylinositol. With one additional metabolite, diacylglycerol, these represent a rich resource of bioactive lipids responsible for recruiting protein effectors and marking membrane compartments. The metabolic map of this pathway and the nature of the binding partner interactions are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506918     DOI: 10.1042/BST0320893

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

Review 1.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

2.  Regulation of type II PIP kinase by PKD phosphorylation.

Authors:  Katherine A Hinchliffe; Robin F Irvine
Journal:  Cell Signal       Date:  2006-03-06       Impact factor: 4.315

Review 3.  Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae.

Authors:  Thomas Strahl; Jeremy Thorner
Journal:  Biochim Biophys Acta       Date:  2007-02-06

4.  Weak acid and alkali stress regulate phosphatidylinositol bisphosphate synthesis in Saccharomyces cerevisiae.

Authors:  Mehdi Mollapour; John P Phelan; Stefan H Millson; Peter W Piper; Frank T Cooke
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 5.  Lipid transfer proteins and instructive regulation of lipid kinase activities: Implications for inositol lipid signaling and disease.

Authors:  Marta G Lete; Ashutosh Tripathi; Vijay Chandran; Vytas A Bankaitis; Mark I McDermott
Journal:  Adv Biol Regul       Date:  2020-07-14

6.  Identification of mitogen-activated protein kinase docking sites in enzymes that metabolize phosphatidylinositols and inositol phosphates.

Authors:  Kevin K Caldwell; Marcos Sosa; Colin T Buckley
Journal:  Cell Commun Signal       Date:  2006-01-30       Impact factor: 5.712

7.  Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II-Benzimidazole Derivatives.

Authors:  Mariola Stypik; Stanisław Michałek; Nina Orłowska; Marcin Zagozda; Maciej Dziachan; Martyna Banach; Paweł Turowski; Paweł Gunerka; Daria Zdżalik-Bielecka; Aleksandra Stańczak; Urszula Kędzierska; Krzysztof Mulewski; Damian Smuga; Wioleta Maruszak; Lidia Gurba-Bryśkiewicz; Arkadiusz Leniak; Wojciech Pietruś; Zbigniew Ochal; Mateusz Mach; Beata Zygmunt; Jerzy Pieczykolan; Krzysztof Dubiel; Maciej Wieczorek
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-27

8.  Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Nancy E Caceres; Maarten Aerts; Béatrice Marquez; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Bart Devreese; Françoise Van Bambeke
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  GxcDD, a putative RacGEF, is involved in Dictyostelium development.

Authors:  Subhanjan Mondal; Dhamodharan Neelamegan; Francisco Rivero; Angelika A Noegel
Journal:  BMC Cell Biol       Date:  2007-06-20       Impact factor: 4.241

10.  A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding.

Authors:  Harold B J Jefferies; Frank T Cooke; Parmjit Jat; Christine Boucheron; Tomonobu Koizumi; Masahiko Hayakawa; Hiroyuki Kaizawa; Takahide Ohishi; Paul Workman; Michael D Waterfield; Peter J Parker
Journal:  EMBO Rep       Date:  2008-01-11       Impact factor: 8.807

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.